AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$MASS

908 Devices Inc.

Price · $MASSvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $MASS in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $MASS in the last 30 days.

Top stories · $MASSMore →
MAY 6·01netHigh

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

908 Devices Inc. reported a strong start to 2026, with first-quarter revenues of $13.4 million, a 14% increase year-over-year, and improved gross margins. The company also announced the acquisition of NIRLAB AG, which expands its narcotics identification capabilities and recurring revenue opportunities. Concurrently, 908 Devices has raised its full-year 2026 revenue outlook to a range of $67.0 million to $70.0 million.

MAY 1·Business Wire

908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026

908 Devices Inc. (Nasdaq: MASS) announced it will report its first-quarter 2026 financial results before the market opens on Wednesday, May 6, 2026. Following the release, company management will host a conference call and webcast at 8:30 a.m. Eastern Time. The webcast will be accessible through the "Investors" section of the company's website.

DEC 30·firehouse.com

908 Devices Launches a 3-in-1 Handheld Analyzer

908 Devices has launched VipIR, a 3-in-1 handheld analyzer designed for rapid and reliable field-based chemical identification of unknown bulk solids and liquids, including hazardous compounds, explosives, and drugs. Utilizing patented Smart Spectral Processing (SSP), VipIR dynamically combines data from FTIR and Raman spectroscopy from a single sample to provide accurate chemical identification. This device aims to streamline processes and remove uncertainty for hazardous response teams and border staff.

News on $MASS

All news →